113 related articles for article (PubMed ID: 35605406)
41. Proanthocyanidin derived from the leaves of Vaccinium virgatum suppresses platelet-derived growth factor-induced proliferation of the human hepatic stellate cell line LI90.
Takami Y; Uto H; Takeshita M; Kai H; Akamatsu E; Moriuchi A; Hasegawa S; Oketani M; Ido A; Kataoka H; Tsubouchi H
Hepatol Res; 2010 Apr; 40(4):337-45. PubMed ID: 20070402
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
Saiz ML; DeDiego ML; López-García D; Corte-Iglesias V; Baragaño Raneros A; Astola I; Asensi V; López-Larrea C; Suarez-Alvarez B
Clin Epigenetics; 2021 Oct; 13(1):187. PubMed ID: 34635175
[TBL] [Abstract][Full Text] [Related]
43. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro.
Jo S; Kim S; Kim DY; Kim MS; Shin DH
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1539-1544. PubMed ID: 32746637
[TBL] [Abstract][Full Text] [Related]
44. The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.
Pang XC; Zhang HX; Zhang Z; Rinkiko S; Cui YM; Zhu YZ
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396184
[TBL] [Abstract][Full Text] [Related]
45. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
46. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.
Sternberg A; McKee DL; Naujokat C
Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679
[TBL] [Abstract][Full Text] [Related]
47. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
48. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
[TBL] [Abstract][Full Text] [Related]
49. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
Xiang Y; Wang M; Chen H; Chen L
Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
[TBL] [Abstract][Full Text] [Related]
50. A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
Xiao T; Lu J; Zhang J; Johnson RI; McKay LGA; Storm N; Lavine CL; Peng H; Cai Y; Rits-Volloch S; Lu S; Quinlan BD; Farzan M; Seaman MS; Griffiths A; Chen B
Nat Struct Mol Biol; 2021 Feb; 28(2):202-209. PubMed ID: 33432247
[TBL] [Abstract][Full Text] [Related]
51. Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study.
Kumar V; Kar S; De P; Roy K; Leszczynski J
SAR QSAR Environ Res; 2022 May; 33(5):357-386. PubMed ID: 35380087
[TBL] [Abstract][Full Text] [Related]
52. Blueberry proanthocyanidins and anthocyanins improve metabolic health through a gut microbiota-dependent mechanism in diet-induced obese mice.
Morissette A; Kropp C; Songpadith JP; Junges Moreira R; Costa J; Mariné-Casadó R; Pilon G; Varin TV; Dudonné S; Boutekrabt L; St-Pierre P; Levy E; Roy D; Desjardins Y; Raymond F; Houde VP; Marette A
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E965-E980. PubMed ID: 32228321
[TBL] [Abstract][Full Text] [Related]
53. p38 MAPK inhibition: A promising therapeutic approach for COVID-19.
Grimes JM; Grimes KV
J Mol Cell Cardiol; 2020 Jul; 144():63-65. PubMed ID: 32422320
[TBL] [Abstract][Full Text] [Related]
54. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
[TBL] [Abstract][Full Text] [Related]
55. A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors.
Jo S; Signorile L; Kim S; Kim MS; Huertas O; Insa R; Reig N; Shin DH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742913
[TBL] [Abstract][Full Text] [Related]
56. Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study.
Al-Shuhaib MBS; Hashim HO; Al-Shuhaib JMB
Comput Biol Med; 2022 Feb; 141():105155. PubMed ID: 34942397
[TBL] [Abstract][Full Text] [Related]
57. Cronobacter sakazakii reduction by blueberry proanthocyanidins.
Joshi SS; Howell AB; D'Souza DH
Food Microbiol; 2014 May; 39():127-31. PubMed ID: 24387862
[TBL] [Abstract][Full Text] [Related]
58. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
59. COVID-19 and L-arginine Supplementations: Yet to Find the Missed Key.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
Curr Protein Pept Sci; 2022; 23(3):166-169. PubMed ID: 35549865
[TBL] [Abstract][Full Text] [Related]
60. Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery.
Mahato S
Med Chem; 2022; 18(8):847-858. PubMed ID: 35156586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
